Special Issue on Advances in Lymphoma Research

Lymphoma is the most common form of hematological malignancy or "blood cancer" in the developed world. It is a group of blood cell tumors that develop from lymphocytes and has two types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Lymphadenopathy or swelling of lymph nodes is the primary presentation in lymphoma. Treatments involve chemotherapy, radiation therapy and surgery. As lymphoma has caused numerous deaths and become a big threaten to our health, further study shows significant importance and necessity.

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring advances in lymphoma research. Potential topics include, but are not limited to:

• Signs and symptoms
• Prognosis and diagnosis
• Stage of lymphoma
• Treatment of lymphoma
• Epidemiology of lymphoma
• Lymphoma in animals
• Limitation and problem
  
  

Authors should read over the journal’s Authors’ Guidelines carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue - Advances in Lymphoma Research” should be chosen during your submission.

According to the following timetable:

Guest Editor:

For further questions or inquiries

Please contact Editorial Assistant at

jct@scirp.org